1. Introduction – Dextromethorphan Hydrobromide Syrup IP:
Dextromethorphan Hydrobromide Syrup IP is an oral liquid pharmaceutical formulation containing Dextromethorphan Hydrobromide as the active pharmaceutical ingredient (API). It is an antitussive medication primarily used for the temporary relief of dry, non-productive cough by acting on the cough centre in the central nervous system and suppressing the cough reflex. The formulation contains Dextromethorphan Hydrobromide IP 15 mg per 5 mL, along with a flavoured syrup base and permitted colouring agents, including Sunset Yellow FCF and Carmoisine. The product is recommended to be stored protected from light to maintain its quality and stability. The Batch Packing Record (BPR) is an essential Good Manufacturing Practice (GMP) document that provides systematic instructions and records for the filling, sealing, labelling, and packaging of Dextromethorphan Hydrobromide Syrup IP. The BPR includes critical activities such as packing material dispensing, line clearance, bottle washing, filling volume verification, cap sealing, leak testing, labelling inspection, and final packing operations. Each activity is documented and verified by authorized Production and Quality Assurance personnel. Critical in-process quality checks include fill volume accuracy, sealing integrity, bottle cleanliness, label correctness, cap perforation, and packaging material reconciliation. These controls help prevent product contamination, packaging defects, and mix-ups during commercial production. The document also provides formats for recording batch yield, rejection analysis, sampling, finished product transfer, and destruction of rejected packaging materials. A properly maintained Batch Packing Record ensures product traceability, GMP compliance, packaging consistency, data integrity, and quality assurance, supporting the safe and reliable distribution of Dextromethorphan Hydrobromide Syrup IP.
Skip to PDF content2. Flow Diagram of Dextromethorphan Hydrobromide Syrup IP:
The Flow Diagram of Dextromethorphan Hydrobromide Syrup IP illustrates the sequential activities involved in the filling, sealing, labelling, and packaging of the pharmaceutical formulation containing Dextromethorphan Hydrobromide IP 15 mg per 5 mL. The batch packing process begins with the initiation of the Batch Packing Record (BPR), preparation of the packing schedule, verification of bulk product status, and dispensing of approved packaging materials. Line clearance is performed by authorized Production and Quality Assurance personnel to ensure that equipment and processing areas are clean and free from previous product materials. The subsequent stages include bottle washing, bottle preparation, syrup filling, cap sealing, and in-process quality checks. Critical parameters such as filling volume, sealing integrity, cap perforation, leakage, and labelling accuracy are monitored according to established procedures.
After successful in-process verification, the filled bottles undergo labelling, cartoning, shipper packing, and final inspection. Packaging materials are reconciled, rejected units are documented, and the final packed quantity is calculated to determine batch yield. The completed batch is transferred to the designated finished goods storage area following applicable quality controls and authorization. This flow diagram provides a systematic overview of the packaging operations, supporting Good Manufacturing Practices (GMP), product traceability, quality assurance, documentation accuracy, and regulatory compliance throughout the batch packing process.
3. Critical Process Parameters (CPP) and Critical Quality Attributes (CQA) of Dextromethorphan Hydrobromide Syrup IP:
The Critical Process Parameters (CPP) and Critical Quality Attributes (CQA) of Dextromethorphan Hydrobromide Syrup IP play an essential role in ensuring the quality, safety, consistency, and regulatory compliance of the finished pharmaceutical product. The formulation contains Dextromethorphan Hydrobromide IP 15 mg per 5 mL, an antitussive agent used for the temporary relief of dry cough.
Critical Process Parameters (CPPs) are process variables whose variation may affect product quality and therefore require appropriate monitoring and control. During batch packing, important parameters include bottle cleanliness, washing conditions, filling volume, filling machine settings, sealing integrity, cap perforation, labelling accuracy, and packaging line controls. The Batch Packing Record specifies routine in-process checks, including hourly filling volume verification, sealing and labelling inspections, and periodic leak testing.
Critical Quality Attributes (CQAs) are physical, chemical, microbiological, and packaging-related properties that must remain within approved specifications to ensure finished product quality. Important attributes include appearance, identity, assay, pH, microbial quality, fill volume, container closure integrity, correct labelling, and stability. The packing process also involves verification of approved packaging materials, line clearance, rejection analysis, batch yield calculation, and reconciliation of printed packaging components. These activities support the prevention of contamination, leakage, mix-ups, and packaging defects. Effective monitoring of CPPs and verification of CQAs help maintain Good Manufacturing Practices (GMP), product traceability, batch consistency, patient safety, and regulatory compliance.
Note: The illustrated control ranges for parameters such as pH, filling tolerance, and sealing torque are examples only. Actual acceptance criteria must be established through approved product specifications, validated processes, and applicable SOPs.